Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

Wookjin Yang(Seoul National University Hospital), Seung‐Hoon Lee(STCube (United States)), Sungwook Yu(Korea University Medical Center), Seongheon Kim(Kangwon National University), Hahn Young Kim(Konkuk University Medical Center), Yoonkyung Chang(The Catholic University of Korea Daejeon St. Mary's Hospital), Mi Sun Oh(Hallym University), Kwang‐Yeol Park(Eulji University), Young Seo Kim(Hallym University), Seong‐Ho Koh(Hanyang University Guri Hospital), Yerim Kim(Hallym University), Jinkwon Kim(Yonsei University), Hyo Suk Nam(Yonsei University), Keun‐Hwa Jung(Seoul National University Hospital), Jeong‐Min Kim(Eulji University), Jong Wook Shin(Chungnam National University), Han‐Jin Cho(Pusan National University), Hyun Goo Kang(Chosun University), Sung‐Il Sohn(Keimyung University), Sung Hyuk Heo(Kyung Hee University), Dong‐Ick Shin(Chungbuk National University Hospital), Hyemin Jang(Ulsan College), Jay Chol Choi(Jeju National University), Kyung‐Hee Cho(Korea University), Hye Seon Jeong(Chungnam National University Hospital), Chulho Kim(Hallym University), Tae‐Jin Song(Ewha Womans University), Hyung‐Min Kwon(Seoul National University), Yeong‐Bae Lee(Gachon University), Jong‐Moo Park(Eulji University), Jun Lee(Hallym University), Beom Joon Kim(Seoul National University Bundang Hospital), Bum Joon Kim(Asan Medical Center), Joon‐Tae Kim(Yonsei University), Eung‐Gyu Kim(Inje University Busan Paik Hospital), Hee-Kwon Park(Inha University Hospital), Seong Hwan Ahn(Chosun University)
Contemporary Clinical Trials
November 25, 2025
Cited by 0


Related Papers